Product Description: Regorafenib-d3 is a deuterium labeled Regorafenib. Regorafenib is a multi-targeted receptor tyrosine kinase inhibitor[1].
Applications: Cancer-Kinase/protease
Formula: C21H12D3ClF4N4O3
References: [1]Wilhelm SM, et al. Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity. Int J Cancer, 2011, 129(1), 245-255.
CAS Number: 1255386-16-3
Molecular Weight: 485.83
Compound Purity: 98.0
Research Area: Cancer
Solubility: 10 mM in DMSO/DMSO : 125mg/mL (ultrasonic)
Target: Autophagy;PDGFR;Raf;RET;VEGFR